Why MDSAP Matters Reimagining Global Medical Device Audits

Importance of MDSAP: Why It Matters in Medical Device Audits

Why MDSAP Matters:

Selling medical devices in more than one country has long meant facing more than one audit. Each regulator wanted to see your quality management system (QMS) on its own terms, on its own schedule. The Medical Device Single Audit Program (MDSAP) reimagines global medical device audits by letting one audit serve several regulators. This guide explains how MDSAP works, how it differs from ISO 13485 auditing, who takes part, and what it means for manufacturers.

Introduction of MDSAP

MDSAP allows a recognized Auditing Organization (AO) to perform a single, comprehensive regulatory audit of a medical device manufacturer. That audit is used by the participating regulatory authorities in place of separate audits by each country, reducing the number of audits a manufacturer faces.

Two clarifications help set expectations:

• It audits the QMS, not the product. MDSAP does not clear devices for sale. You still need each market's product registration, such as a US premarket submission or a Canadian device licence.
• You choose the markets. The audit covers the requirements of the participating jurisdictions you sell in or plan to sell in.

Why was MDSAP Introduced?

MDSAP was introduced to streamline global regulatory compliance and make QMS audits more efficient for medical device manufacturers. It began as a pilot in 2014 under the International Medical Device Regulators Forum (IMDRF) and became fully operational in 2017. Its goals reflect a commitment to:

• Harmonization: a common audit model and shared interpretation of requirements
• Transparency: audit reports that participating regulators can see and rely on
• Improved patient safety: consistent oversight across multiple jurisdictions

MDSAP Audit Processes and Key Requirements

MDSAP audits follow a common audit model. The audit criteria combine ISO 13485:2016 with the QMS-related requirements of the participating jurisdictions the manufacturer has included in scope. The audit is organized into seven areas, often called chapters:

1. Management
2. Device marketing authorization and facility registration
3. Measurement, analysis, and improvement
4. Medical device adverse events and advisory notices reporting
5. Design and development
6. Production and service controls
7. Purchasing

Findings are graded on a common 1 to 5 scale, with rules for escalating serious or repeated nonconformities. Higher grades trigger notification to the participating regulators. Only recognized AOs can conduct MDSAP audits and issue MDSAP certificates, and regulators may witness some audits.

MDSAP Audit Cycle

The audit cycle covers three years and then repeats:

Importance of MDSAP in Medical Device Audits

MDSAP matters because it changes how regulators and manufacturers handle audits:

• Fewer duplicate audits. One audit can replace several separate ones, reducing disruption and cost.
• Regulatory reliance. Participating regulators use MDSAP reports as part of their own decisions. The US FDA accepts MDSAP audit reports as a substitute for routine inspections, though it can still inspect "for cause" and before approving certain products.
• A market requirement in Canada. Health Canada requires MDSAP certification for manufacturers of Class II, III, and IV devices that hold or want a Canadian device licence.
• Consistency. The same audit model and grading approach apply everywhere, so manufacturers and regulators speak the same language.
• Convergence in practice. MDSAP is one of the clearest examples of regulators aligning around ISO 13485 and shared audit practices, a trend that also shows up in the FDA's QMSR.

The value depends on where you sell. A company active in Canada and Brazil gains far more than one selling only in the US and EU. The EU is an observer, not a participant, so MDSAP does not replace notified body audits under the EU MDR.

How is MDSAP conducted?

In practice, an MDSAP audit follows these steps:

1. Select an AO. Choose a recognized Auditing Organization and agree the scope, including which participating jurisdictions to cover.
2. Prepare. Map your QMS against ISO 13485:2016 and the country-specific requirements, and run an internal readiness review.
3. Stage 1. The AO reviews documentation and readiness.
4. Stage 2. Auditors assess implementation and effectiveness across the seven audit chapters, including sample records for adverse event reporting, registration, design, production, and purchasing.
5. Nonconformities. Findings are graded 1 to 5. You investigate root causes, respond, and correct within the required timelines, and repeated or serious issues escalate.
6. Certification and reporting. The AO issues the MDSAP certificate, and the audit reports become available to the participating regulators.
7. Surveillance and recertification. Annual surveillance audits follow, then recertification, then the cycle repeats. Special audits can be added at any point.

DIFFERENCE BETWEEN ISO 13485:2016 & MDSAP AUDITING

ISO 13485:2016 sets the QMS requirements for medical devices, while MDSAP is an audit program that builds on it by adding regulatory requirements of participating jurisdictions. An ISO 13485 certificate alone does not satisfy MDSAP, and the two audits are separate.

Key Benefits of MDSAP for Medical Device Manufacturers

The main advantages of MDSAP are:

• Reduced audits: one program in place of many
• Consistent interpretation: the same requirements read the same way by every regulator
• Standardized procedures: a common audit model and grading system
• Time and cost savings: less duplicated preparation and fewer inspection visits
• Enhanced transparency: shared reports and predictable expectations

There are trade-offs too:

• Initial investment: higher AO fees and the effort of building the required documentation
• Resistance to change: teams used to country-by-country audits need to adapt
• Complexity of integration: bringing several jurisdictions' requirements into one QMS takes careful planning

Weigh these against the markets you actually serve.

Parameters

The comparison table uses five parameters, and each has practical meaning:

• Scope tells you what is being audited. ISO 13485 covers the QMS, while MDSAP adds jurisdiction-specific regulatory requirements.
• Participating countries show where the audit result can be used.
• Nonconformity grading decides how serious a finding is and whether it triggers escalation to regulators.
• Adverse event reporting determines whether you can show that you report to each authority within its required timeframe.
• Documentation determines how much additional evidence you need for each participating country.

ISO 13485:2016

ISO 13485:2016 is the international quality management standard for medical devices. It covers management responsibility, resource management, product realization, and measurement, analysis, and improvement, with risk-based thinking throughout. It applies worldwide and is not tied to any country's regulations. Many regulators base their QMS expectations on it. The FDA's QMSR now incorporates it by reference, and the EU and Indian frameworks lean on it too.

ISO 13485 auditing confirms that your QMS meets the standard. It does not, by itself, confirm that you meet each country's additional requirements.

MDSAP

MDSAP takes ISO 13485:2016 as its base and adds what regulators need to see in their own jurisdictions. That includes marketing authorization and facility registration, adverse event and advisory notice reporting, and country-specific labeling and documentation. It uses one audit model, one grading system, and one recognized Auditing Organization to deliver results that several regulators can use.

MDSAP is an audit program, not a certificate of product approval. It works alongside your product registrations and does not replace them.

MDSAP Participating Countries and Regulatory Authorities

Five regulatory authorities participate as full members:

Beyond the five members, the program has official observers, including the European Union, the UK's MHRA, and the WHO, and affiliate members such as Argentina, South Korea, and Singapore. Check the current membership before relying on it, as it changes over time.

Conclusion

MDSAP replaces a patchwork of national audits with a single audit that several regulators can rely on. It rests on ISO 13485:2016 and adds the regulatory requirements of the participating jurisdictions. For manufacturers, the benefits are fewer audits, consistent interpretation, and savings in time and cost, balanced against the up-front investment and the work of aligning a QMS with several regulators at once.

MDSAP is not right for every company. It is mandatory for Canadian licences in higher classes and optional elsewhere, so the decision should follow your market plan. For manufacturers active in several participating countries, it is one of the most efficient ways to keep the QMS audit-ready and support global growth.

Frequently Asked Questions About MDSAP

1. Is MDSAP certification mandatory for medical device manufacturers?

Only in one participating country. Health Canada requires an MDSAP certificate for manufacturers of Class II, III, and IV devices that hold or apply for a Canadian device licence. In the US, Brazil, Australia, and Japan, MDSAP is voluntary. It is a way to use one audit for those regulators, though each authority uses the reports in its own way. You can still market devices in those countries without MDSAP, but you must meet the applicable QMS requirements through their standard routes.

2. Can one MDSAP audit provide access to multiple medical device markets?

One audit covers the QMS requirements of the participating jurisdictions you include. It does not grant market access on its own. You still need each market's product authorization, such as a US premarket submission, a Canadian licence, or a Brazilian or Australian registration. MDSAP also does not replace EU MDR conformity assessment by a notified body. It reduces audit duplication, not product registration work.

3. How does MDSAP simplify medical device regulatory audits?

It replaces several separate audits with a single audit run by a recognized Auditing Organization. The audit uses a common audit model and a common 1 to 5 grading system, so requirements are read consistently. Participating regulators can access the results, and the FDA accepts MDSAP reports in place of routine inspections. That reduces preparation, disruption, and duplicated effort.

4. Who needs MDSAP certification?

Any manufacturer that wants a Canadian Class II, III, or IV device licence needs it. Manufacturers active in two or more participating markets, or those who want to reduce routine regulatory inspections, often adopt it voluntarily. Any manufacturer worldwide can take part if its products fall under at least one participating regulator's scope. Companies selling only in the US and EU may find the added cost hard to justify.

5. How does MDSAP help manufacturers improve regulatory compliance?

The audit model ties your QMS directly to regulatory obligations, including registration, marketing authorization, and adverse event reporting, so gaps show up early. The structured grading system makes it clear which problems matter most. Preparing for MDSAP pushes companies to document processes clearly, link complaints and reports to corrective action, and build the traceability that also helps in FDA, EU, and other audits. A digital quality system can make this easier to sustain.